Featured Research

from universities, journals, and other organizations

How specialized pacemaker works at biological level to strengthen failing hearts: Findings could lead to 'pacemaker in a bottle'

Date:
September 15, 2011
Source:
Johns Hopkins Medical Institutions
Summary:
Heart specialists have figured out how a widely used pacemaker for heart failure, which makes both sides of the heart beat together to pump effectively, works at the biological level. Their findings may open the door to drugs or genetic therapies that mimic the effect of the pacemaker and to new ways to use pacemakers for a wider range of heart failure patients.

Heart specialists at Johns Hopkins have figured out how a widely used pacemaker for heart failure, which makes both sides of the heart beat together to pump effectively, works at the biological level. Their findings, published in the Sept. 14 issue of Science Translational Medicine, may open the door to drugs or genetic therapies that mimic the effect of the pacemaker and to new ways to use pacemakers for a wider range of heart failure patients.

All sides of the heart's left ventricle (the main pumping chamber) need to beat in concert with one another in order for the heart to pump blood effectively to the rest of the body. In many people who suffer from heart failure, the right and left sides of the ventricle are out of sync, with one side contracting while the other is relaxed.

Several years ago, Johns Hopkins researchers helped develop a modified pacemaker that synchronizes the heart beats and restores normal contractions. That treatment, called cardiac resynchronization therapy (CRT), was approved by the Food and Drug Administration in 2001 and is widely used today to improve symptoms and enable people to live longer. However, the reasons why it worked at the biological level were unknown until now.

David Kass, M.D., professor of medicine and biomedical engineering at the Johns Hopkins University School of Medicine, who led the development of CRT, is senior author of the new study. "We have revealed a key and important underlying biological mechanism that helps us understand how CRT works. With this information, we can work to develop completely new treatments, such as a drug or gene therapy, to essentially have a kind of 'pacemaker in a bottle' to help a wide variety of patients with a failing heart," says Kass, who is also a cardiologist at the Johns Hopkins Heart and Vascular Institute.

When investigating the changes that were occurring with CRT at the basic science level, Kass and his colleagues found that resynchronizing the heart makes the heart muscle more responsive to adrenaline, which stimulates pumping ability.

"What we learned," says Kass, "is that the modified pacemaker used in CRT raises the levels of regulator of G-protein-signaling (RGS) proteins in the heart. The RGS proteins direct the activity of G proteins, which are messengers that tell the heart and other organs what to do."

In heart failure, levels of a particular G protein, known as Gi, go up. Gi inhibits heart muscle pumping, getting in the way of another protein -- Gs -- that stimulates the heart muscle, thereby preventing Gs from doing its job. CRT restores the normal balance of Gi and Gs.

Kass uses a car analogy to explain the process. The Gs proteins represent the accelerator. The Gi proteins represent the brake. In heart failure, it's like driving with one foot on the gas and the other on the brake. He says that CRT takes the foot off the brake, inhibiting the Gi proteins, so that not only does the entire left ventricle pump in a coordinated fashion, but the heart muscle now responds to hormones, such as adrenaline, more like a healthy heart.

While the typical pacemaker only has one wire that goes to the right side of the heart, the modified CRT pacemaker that Kass and his colleagues first helped develop has two wires. The second lead goes to the surface of the left ventricle, so that both sides of the heart are stimulated at the same time.

Usually, translational research begins at the laboratory bench, in cellular, molecular or animal models, and then discoveries are tested in people. However, with CRT, the modified pacemakers were developed first and offered to patients suffering from severe heart failure. The results were significant: helping hearts become stronger and healthier. In published studies, the majority of patients receiving CRT had less fatigue and shortness of breath, and better long-term survival.

"This was remarkable," notes Kass, "since CRT also made the heart do more work, and we had never had a heart failure treatment that made the heart work more, while also decreasing mortality." The next step for Kass and his colleagues was to go into the basic science lab to try to understand why and how CRT worked.

The majority of people with heart failure are not offered CRT because the two sides of their heart are beating in sync. Out of six million heart failure patients in the United States, an estimated one million have the type of disease that CRT was designed to treat. However, in another part of the study, the researchers discovered in animal models that if a heart that beat in synch was temporarily forced to beat out of sync, then was resynchronized, the heart muscle improved, Gi declined and the response to adrenalin was better.

"That finding gives us yet another avenue to explore," says Kass. "By temporarily putting a heart out of sync and then letting it go back, we may be able to trigger the type of biological effect that CRT produced. This theoretically could be applied to patients sooner than developing a drug or gene therapy. Kass and his colleagues are actively pursuing both gene therapy and modified pacing approaches.

In addition to Kass, other Johns Hopkins researchers involved in this study were lead author Khalid Chakir, Ph.D.; Charlene Depry; Veronica Dimaano, M.D.; Theodore Abraham, M.D.; Gordon Tomaselli, M.D.; Manling Zhang, M.D.; Eiki Takimoto, M.D., Ph.D.; and Jin Zhang, Ph.D. From the Gerontology Research Center of the National Institute on Aging: We-Zhong Zhu and Rui Ping Xiao. Mark Vanderheyden, M.D., and Jozef Bartunek, M.D., from Belgium were authors as well as Shu-bai Liu, Ph.D., and Yang Xiang, Ph.D., from the University of Illinois at Urbana and Nickolai Dulin, Ph.D., from the University of Chicago.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Journal Reference:

  1. Khalid Chakir, Charlene Depry, Veronica L. Dimaano, Wei-Zhong Zhu, Marc Vanderheyden, Jozef Bartunek, Theodore P. Abraham, Gordon F. Tomaselli, Shu-Bai Liu, Yang K. Xiang, Manling Zhang, Eiki Takimoto, Nickolai Dulin, Rui Ping Xiao, Jin Zhang, David A. Kass. Gαs-Biased β2-Adrenergic Receptor Signaling from Restoring Synchronous Contraction in the Failing Heart. Science Translational Medicine, 2011; 3 (100): 100ra88 DOI: 10.1126/scitranslmed.3001909

Cite This Page:

Johns Hopkins Medical Institutions. "How specialized pacemaker works at biological level to strengthen failing hearts: Findings could lead to 'pacemaker in a bottle'." ScienceDaily. ScienceDaily, 15 September 2011. <www.sciencedaily.com/releases/2011/09/110914143625.htm>.
Johns Hopkins Medical Institutions. (2011, September 15). How specialized pacemaker works at biological level to strengthen failing hearts: Findings could lead to 'pacemaker in a bottle'. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2011/09/110914143625.htm
Johns Hopkins Medical Institutions. "How specialized pacemaker works at biological level to strengthen failing hearts: Findings could lead to 'pacemaker in a bottle'." ScienceDaily. www.sciencedaily.com/releases/2011/09/110914143625.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins